ATE258435T1 - Pinolensäure gegen diabetes - Google Patents

Pinolensäure gegen diabetes

Info

Publication number
ATE258435T1
ATE258435T1 AT01200471T AT01200471T ATE258435T1 AT E258435 T1 ATE258435 T1 AT E258435T1 AT 01200471 T AT01200471 T AT 01200471T AT 01200471 T AT01200471 T AT 01200471T AT E258435 T1 ATE258435 T1 AT E258435T1
Authority
AT
Austria
Prior art keywords
pinolene
acid against
against diabetes
acid
diabetes
Prior art date
Application number
AT01200471T
Other languages
English (en)
Inventor
Louise Brown
Frederick William Cain
Martin Richard Green
Julia Sarah Rogers
Original Assignee
Unilever Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Nv filed Critical Unilever Nv
Application granted granted Critical
Publication of ATE258435T1 publication Critical patent/ATE258435T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01200471T 2000-02-24 2001-02-12 Pinolensäure gegen diabetes ATE258435T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00301440 2000-02-24

Publications (1)

Publication Number Publication Date
ATE258435T1 true ATE258435T1 (de) 2004-02-15

Family

ID=31197762

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01200471T ATE258435T1 (de) 2000-02-24 2001-02-12 Pinolensäure gegen diabetes

Country Status (4)

Country Link
EP (1) EP1129711B1 (de)
AT (1) ATE258435T1 (de)
DE (1) DE60101859T2 (de)
ES (1) ES2213666T3 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1302114A3 (de) * 2001-10-16 2004-01-14 Loders Croklaan B.V. Mischungen zur Förderung der Glucoseaufnahme
GB0311081D0 (en) 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
GB2422373B (en) 2003-08-18 2008-05-21 Btg Int Ltd Treatment of neurodegenerative conditions
ES2300838T3 (es) * 2003-10-30 2008-06-16 Lipid Nutrition B.V. Producto alimenticio que contiene extracto de agujas de pino.
GB0514463D0 (en) * 2005-01-31 2005-08-17 Loders Croklaan Bv Use of pinolenic acid
GB0504362D0 (en) 2005-03-02 2005-04-06 Btg Int Ltd Cytokine modulators
ATE513482T1 (de) * 2007-10-29 2011-07-15 Lipid Nutrition Bv Suppen- oder sossenzusammensetzung und herstellungsverfahren dafür
EP2090172A1 (de) * 2007-10-29 2009-08-19 Lipid Nutrition B.V. Teigzusammensetzung
US10631564B2 (en) 2015-06-19 2020-04-28 University Of Southern California Enterically coated microparticle compositions and methods for modified nutrient delivery
US10744070B2 (en) 2015-06-19 2020-08-18 University Of Southern California Enteral fast access tract platform system
US12599544B2 (en) 2024-05-09 2026-04-14 Alsteni Medical, Inc. Intraoral gastrointestinal access device and related methods

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6158536A (ja) * 1984-08-31 1986-03-25 Nippon Oil & Fats Co Ltd 栄養組成物
US5902726A (en) * 1994-12-23 1999-05-11 Glaxo Wellcome Inc. Activators of the nuclear orphan receptor peroxisome proliferator-activated receptor gamma
DE19503993A1 (de) * 1995-02-08 1996-08-14 Johann Friedrich Dr Med Desaga Verwendung eines Produktes zur enteralen Versorgung mit Lebensmittelinhaltsstoffen oder Arzneimittelinhaltsstoffen
FR2756465B1 (fr) * 1996-12-03 1999-02-19 D A Noste Additif alimentaire, composition cosmetique et medicament a base d'huile de graines de pin
KR100529793B1 (ko) * 1997-01-27 2005-11-23 링 지 솔잎 추출물 및 이것의 용도
ES2265865T3 (es) * 1999-09-30 2007-03-01 Loders Croklaan B.V. Composiciones que contienen acido pinolenico y su uso como un componente para la salud.

Also Published As

Publication number Publication date
ES2213666T3 (es) 2004-09-01
EP1129711A2 (de) 2001-09-05
EP1129711A3 (de) 2001-09-12
DE60101859T2 (de) 2004-12-30
DE60101859D1 (de) 2004-03-04
EP1129711B1 (de) 2004-01-28

Similar Documents

Publication Publication Date Title
PL2162019T3 (pl) Kompozycja lipidowa do poprawy czynności mózgu
IL183401A0 (en) Compositions comprising ornithine and phenylacetate of phenylbutyrate for treating hepatic encephalopathy
PT2412250E (pt) Composição alimentar para pacientes no estado prodrómico de demência
DK1283038T3 (da) Dögnrytmenormaliserende sammensætninger
DE60101859D1 (de) Pinolensäure gegen Diabetes
MX2007011031A (es) Tratamiento con estatina y acidos grasos omega-3 y un producto de combinacion de los mismos.
DE69927125D1 (de) Zusammensetzung gegen Erhöhung oder zur Herabsetzung des Blutzuckerspiegels
AP2005003367A0 (en) Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis.
WO2008036353A3 (en) Omega-3 diglyceride emulsions
CA2399039A1 (en) Hyaluronic acid gel, method of its production and medical material containing it
WO2006017692A3 (en) Novel fenofibrate formulations and related methods of treatment
WO2006081273A8 (en) 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroayryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immunostimulant activity
ATE323480T1 (de) Zusammensetzungen, enthaltend pinolensäure sowie deren verwendung zur gesundheitserhaltung
GB0514463D0 (en) Use of pinolenic acid
DE602006020070D1 (de) Verringerung von schwindel, einer nebenwirkung im zusammenhang mit einer pirfenidon-therapie
BR0213124A (pt) Alimentos para animais incluindo ativos e métodos de uso dos mesmos
EP1158977A4 (de) Methoden und zusammenstellungen zur verabreichungeines cyclooxygenase-2-hemmers
EP2229957A3 (de) Stabilisierung von wässrigen Zusammensetzungen von 18F-markierter 2-Fluoro-2-deoxy-D-Glukose mit Ethanol
WO2007018588A8 (en) Stable pharmaceutical composition comprising linezolid form iv
PL1799204T3 (pl) Kompozycja zawierająca kwasy tłuszczowe omega-3 i omega-6
CA2353451A1 (en) Method of increasing fat firmness and improving meat quality in animals
WO2008063772A3 (en) Resolvin d series and protectin d1 mitigate acute kidney injury
ATE462418T1 (de) Stabile pharmazeutische zubereitungen zur kontrollierten freisetzung von fenofibrat and pravastatin
WO2005053669A8 (fr) Utilisation des acides gras polyinsatures omega 3 dans l'apnee du sommeil
EP1269991A3 (de) Topische Zusammensetzung die Ethyllinoleat und/oder Triethylzitrat mit Synergisten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties